| Publisher: Radcliffe Medical Media (Total: 6 journals) [Sort by number of followers]
| ||||||||||||||
Similar Journals
|
European Cardiology Review
Number of Followers: 0  Open Access journalISSN (Print) 1758-3756 - ISSN (Online) 1758-3764 Published by Radcliffe Medical Media  [6 journals]
|
- Coronary Spasm: Ethnic and Sex Differences
Authors: dbarot525787
Abstract: Coronary Spasm: Ethnic and Sex Differences Coronary spasm (CS) represents an important functional cardiac disorder, characterised by exaggerated vasoconstriction of the coronary arteries leading to transient myocardial ischaemia and anginal chest pain. Attilio Maseri’s work was pioneering in demonstrating the clinical relevance of CS as a functional vasomotor disorder, which is associated with an increased risk of non-fatal cardiovascular events and substantial morbidity due...
PubDate: Wed, 07 Jun 2023 07:11:46 +000
- Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum
Authors: dbarot525787
Abstract: Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum Hypertensive disorders of pregnancy (HDP) include a spectrum of complications, such as gestational hypertension (GH) and pre-eclampsia/toxaemia (PET), which affect 5–10% and 3–5% of pregnancies, respectively.1 The incidence of HDP has increased during the past two decades, and they still account for 10–22% of maternal mortality worldwide.2,3 Systemic cardiovascular impairment is a pathognomonic feature of...
PubDate: Wed, 07 Jun 2023 06:25:04 +000
- When Should We Start Sodium–Glucose Co-transporter Inhibitors in
Patients with Heart Failure' The Importance of Early Intervention
Authors: dbarot525787
Abstract: When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure' The Importance of Early Intervention Sodium–glucose co-transporter (SGLT2) inhibitors were primarily developed as anti-diabetic drugs to increase the excretion of glucose in the urine. However, SGLT2 inhibitors have been reported to have multifactorial effects, such as renal protection and improvement of myocardial energy metabolism and anaemia symptoms, which may exert protection a...
PubDate: Wed, 07 Jun 2023 05:53:10 +000
- Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of
Inflammatory Cardiovascular Disease
Authors: dbarot525787
Abstract: Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) was discovered in 1986 by Sen and Baltimore.1 NF-κB is a dimeric transcription factor, originally found as an inducible B cell-specific factor that binds to the κB motif in the enhancer of the immunoglobulin light chain.2 NF-κB plays a crucial role in the regulation of immune responses and inflammat...
PubDate: Wed, 07 Jun 2023 05:00:50 +000
- Mechanisms of Coronary Artery Spasm
Authors: dbarot525787
Abstract: Mechanisms of Coronary Artery Spasm The ISCHEMIA and REVIVED-BCIS2 trials have highlighted that percutaneous coronary intervention (PCI) in patients with stable coronary syndrome provides limited additional prognostic benefits when used on top of optimal medical therapy.1,2 This has led to much attention being paid to coronary vasomotion abnormalities regardless of the presence or absence of obstructive coronary artery disease. Coronary vasomotion is regulated by multiple me...
PubDate: Mon, 29 May 2023 09:18:10 +000
- Management of Coronary Artery Spasm
Authors: dbarot525787
Abstract: Management of Coronary Artery Spasm The most typical and well-defined clinical condition caused by coronary artery spasm (CAS) is Prinzmetal or variant angina.1 Variant angina is characterised by recurrent angina attacks that usually last 5–10 min, but sometimes only 30–60 s, and occur at rest, frequently at night, and usually in the absence of apparent triggering factors. However, exercise may trigger CAS in approximately 25% of patients.2 The ECG recorded during angina att...
PubDate: Wed, 17 May 2023 10:03:01 +000
- Use of Heart Failure-Exacerbating Medications among Heart Failure Patients
in a Tertiary Referral Centre in Malaysia
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Use of Heart Failure-Exacerbating Medications among Heart Failure Patients in a Tertiary Referral Centre in Malaysia Background: The American Heart Association (AHA) released a scientific statement consists of list of drugs that may exacerbate heart failure in 2016. Literature review showed the prevalence of the use of heart failure-exacerbating medications is ranging from 25% to 48% among heart failure adults.Objective: The aim of this study is to evaluate the prevalence ...
PubDate: Tue, 25 Apr 2023 14:26:16 +000
- Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C
Levels than Recommended in Guidelines: Results from the Observational
HEYMANS Study
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study Objective: We examined clinical characteristics and LDL-C lowering in patients initiating evolocumab in real-world practice in a Central and Eastern European (CEE) cohort from the pan-European HEYMANS study.Materials and methods: Patients from Bulgaria, Czech Republic, and Slovakia were enrolled at initiation of evol...
PubDate: Tue, 25 Apr 2023 14:26:15 +000
- Role of Water-soluble Vitamins in Reducing the Risk of Cardiovascular
Heart Disease in Premature Ovarian Insufficiency Patients
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Role of Water-soluble Vitamins in Reducing the Risk of Cardiovascular Heart Disease in Premature Ovarian Insufficiency Patients Objective: To analyse the effect of vitamin B and vitamin C on premature ovarian insufficiency patients who are at higher risk of cardiovascular disease.Materials and methods: The latest articles on the topic of early menopause and cardiovascular risk were reviewed from PubMed and Science Direct and were interlinked to find solutions.Results: In...
PubDate: Tue, 25 Apr 2023 14:26:14 +000
- Pharmacologic Cardiac Stress (PS-SPECT): Still Valuable for Prognosis in
Chronic Coronary Syndrome
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Pharmacologic Cardiac Stress (PS-SPECT): Still Valuable for Prognosis in Chronic Coronary Syndrome Objective: Pharmacologic cardiac stress SPECT (PS-SPECT) has been commonly used test for non-invasive evaluation of ischaemic heart disease (IHD) in patients unable to exercise. New techniques (like cardiac CT-scan) are replacing its use in many clinical scenarios and scientific publications. However, it is still the only available test for non-invasive evaluation of some patie...
PubDate: Tue, 25 Apr 2023 14:26:13 +000
- Long-term Mortality Predictors of Patients Evaluated with Pharmacologic
Cardiac Stress SPECT (PS-SPECT) for Suspicion of Chronic Coronary Syndrome
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Long-term Mortality Predictors of Patients Evaluated with Pharmacologic Cardiac Stress SPECT (PS-SPECT) for Suspicion of Chronic Coronary Syndrome Objective: Pharmacologic cardiac stress SPECT (PS-SPECT) is used for non-invasive evaluation and risk stratification of patients with suspected chronic ischaemic heart disease (IHD) unable to exercise. Aim of the study was to identify predictors of mortality in those patients.Materials and methods: Retrospective study of 1.214 p...
PubDate: Tue, 25 Apr 2023 14:26:12 +000
- The Importance of Oxidative Stress Biomarkers and the Need of Antioxidant
Therapy in the Control of Cardiac Arrhythmias
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: The Importance of Oxidative Stress Biomarkers and the Need of Antioxidant Therapy in the Control of Cardiac Arrhythmias Antioxidants, drugs or food, have an important role in combating the effects of oxidative stress, which is involved pathophysiologically in oxidation processes, triggering various pathologies, including cardiovascular ones.Objective: Assessment of oxidative stress level, due to decrease of specific antioxidant biomarkers – superoxide dismutase-SOD and glu...
PubDate: Tue, 25 Apr 2023 12:55:19 +000
- Difficulties in Monitoring Antithrombotic Therapy in Patients with Atrial
Fibrillation and Post-traumatic Hepatic and Splenic Visceral Haematomas
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Difficulties in Monitoring Antithrombotic Therapy in Patients with Atrial Fibrillation and Post-traumatic Hepatic and Splenic Visceral Haematomas In the evolution of cardiac patients with AF, antithrombotic treatment favours the occurrence of haemorrhagic complications in conditions of apparently minor traumas – with voluminous visceral haematomas requiring medical-surgical and therapeutic management, clinical investigation and therapeutic monitoring.Objective: To evaluate...
PubDate: Tue, 25 Apr 2023 12:55:18 +000
- Randomised Double-blind Placebo-Controlled Multicentre Trial for the
Effects of Yokukansan in Smokers with Depressive Tendencies
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies Background: Smoking and depression are closely related and form a vicious cycle. Yokukansan has the effect of calming neuropsychiatric symptoms such as anger and irritation. We examined the efficacy of Yokukansan during smoking cessation (SC) therapy in smokers with depressive tendencies.Methods: A multicentre, double-blind, randomised, placebo-c...
PubDate: Tue, 25 Apr 2023 12:55:17 +000
- The Relationship between Neutrophil to Lymphocyte Ratio with
Rehospitalisation and Mortality in Patients with Acute Coronary Syndrome
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: The Relationship between Neutrophil to Lymphocyte Ratio with Rehospitalisation and Mortality in Patients with Acute Coronary Syndrome Background: Cardiovascular disease is still the leading cause of death globally and is expected to continue to increase. In Indonesia, ischemic heart disease is the main cause of morbidity and mortality based on acute coronary syndrome (ACS) is a manifestation of coronary heart disease where there is decompensation of the heart due to narrowin...
PubDate: Tue, 25 Apr 2023 12:55:14 +000
- Effect of Vitamin D in Experimental Pulmonary Arterial Hypertension in
Rats: Possible Role of eNOS-mediated Signalling Pathways
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Effect of Vitamin D in Experimental Pulmonary Arterial Hypertension in Rats: Possible Role of eNOS-mediated Signalling Pathways Objective: Vitamin D deficiency is associated with a poor prognosis of pulmonary arterial hypertension (PAH).Materials and methods: Rats were fed on a vitamin D deficient diet with exposure to filtered fluorescent light to induce vitamin D deficiency in rats. MCT 50 mg/kg was used to induce PAH in rats. Normal rats were divided into vitamin D 100...
PubDate: Tue, 25 Apr 2023 12:29:10 +000
- HDL Mimetics Enhances Mitochondrial Function via Stimulation of
PGC1-α
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α Objective: Various large clinical trials have shown that high-density lipoprotein (HDL) has pleiotropic effects for anti-atherosclerosis, and an enhanced HDL by CETP inhibitor improves glucose metabolism. In addition, HDL and apolipoprotein A-I (ApoA- I), the major protein of HDL had been demonstrated to enhance mitochondrial function in skeletal muscle in vitro.Materials and methods: One of the HDL mim...
PubDate: Tue, 25 Apr 2023 12:14:22 +000
- Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute
Coronary Syndrome
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome Objectives: To determine the incidence of bleeding in patients with non-ST-segment elevation acute coronary syndrome (NST-ACS) after antiplatelet pretreatment.To determine the percentages of patients diagnosed with acute aortic syndrome, pulmonary embolism, or stroke after pretreatment for initially misdiagnosed NST-ACS.To analyse delays in coronary-artery bypass grafts (CABG) in rela...
PubDate: Tue, 25 Apr 2023 12:09:43 +000
- Evaluating the Effects of Melatonin on the Oxidative Stress and Duration
of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A
Randomised Controlled Trial
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Evaluating the Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A Randomised Controlled Trial Objective: AF is a common complication following coronary artery bypass graft (CABG) surgery, which may be due to oxidative stress during CABG and can lead to increase the length of hospital stay and the risk of morbidity and mortality. This study assessed the efficacy of melatonin in reducing necrosis a...
PubDate: Tue, 25 Apr 2023 12:04:18 +000
- Non-invasive Evaluation of Coronary Flow Reserve in Cardiac Syndrome X
Patients
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Non-invasive Evaluation of Coronary Flow Reserve in Cardiac Syndrome X Patients Objective: Evaluation of the coronary flow reserve in cardiac syndrome X patients (patients with coronary microvascular disease, CMVD; patients with chest pain, positive exercise ECG and normal coronary angiograms) non-invasively using transthoracic Doppler echocardiography (TTDE) and mitral annular plane systolic excursion (MAPSE) marker.Methods: This prospective study included 90 patients wit...
PubDate: Tue, 25 Apr 2023 11:22:37 +000
- Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver
Disease
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease Objective: To quantify the cardiovascular risk in Romanian patients with non-alcoholic fatty liver disease (NAFLD).Materials and methods: This is a prospective observational investigation on patients with NAFLD to determine the cardiovascular risk using Framingham cardiac risk score and SCORE cardiovascular risk.Results: We found an average Framingham risk of 12.21239%, statistically signifi...
PubDate: Tue, 25 Apr 2023 11:18:48 +000
- Statin Therapy and the Assessment of Hepatoprotection in Patients with
Dyslipidaemia
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Statin Therapy and the Assessment of Hepatoprotection in Patients with Dyslipidaemia Introduction: The indication for statin treatment is common in patients with dyslipidaemia due to the risks of cardiovascular and metabolic diseases and their complications. Statins reduce the synthesis of liver cholesterol by competitively inhibiting the enzyme reductase-3-hydroxy-3- methylglutaryl-coenzyme A (HMG-CoA reductase), with many beneficial effects, but may cause liver or muscle d...
PubDate: Tue, 25 Apr 2023 11:12:58 +000
- Approach to Anticoagulation Therapy in Patients with Combined Atrial
Fibrillation and Coronary Artery Stents: A Review of the Literature
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Approach to Anticoagulation Therapy in Patients with Combined Atrial Fibrillation and Coronary Artery Stents: A Review of the Literature Introduction: Patients with AF on oral anticoagulant therapy (OAC) may require percutaneous coronary intervention (PCI) with use of dual antiplatelet therapy (DAPT). Combined antithrombotic therapy with OAC plus DAPT puts the patient at increased risk of bleeding while sub-therapeutic regimens increase the risk of ischemic events. The optim...
PubDate: Tue, 25 Apr 2023 11:09:12 +000
- Appropriateness of Antiplatelet Pretreatment in Non-ST-segment Elevation
Acute Coronary Syndrome: Differences Between Unstable Angina and Acute
Myocardial Infarction
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Appropriateness of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome: Differences Between Unstable Angina and Acute Myocardial Infarction Objective: To evaluate the appropriateness of antiplatelet pretreatment in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). To determine whether the appropriateness differs between patients with unstable angina and those with acute myocardial infarction.Materials and methods: This pro...
PubDate: Tue, 25 Apr 2023 11:03:58 +000
- LDL-C Reduction in Diabetic Patients after Percutaneous Coronary
Intervention: Is There any Difference with Non-diabetic'
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic' Objective: The clinical benefit of lowering LDL cholesterol (LDL-C) in secondary prevention is well known from clinical trials, especially in diabetic patients. The aim of this study was to evaluate LDL-C reduction in diabetic versus non-diabetic patients after percutaneous coronary intervention in clinical praxis.Materials and methods: An observational...
PubDate: Tue, 25 Apr 2023 11:00:18 +000
- The Predictive Value of NT-proBNP across Glomerular Filtration Rate
Subsets in Heart Failure Treated Patients
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: The Predictive Value of NT-proBNP across Glomerular Filtration Rate Subsets in Heart Failure Treated Patients Objective: We aimed to assess the predictive value of high NT-proBNP for all-cause long-term mortality in heart failure (HF) patients for different subsets of renal function defined by the estimated glomerular filtration rate (eGFR).Materials and methods: HF patients admitted consecutively to our cardiology department from 2011 to 2014 were retrospectively included...
PubDate: Tue, 25 Apr 2023 10:55:06 +000
- How to Improve Clinical Outcomes and Reduce Cardiovascular Risk in Older
People with Cardiovascular Disease: Bridging Evidence Gaps
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: How to Improve Clinical Outcomes and Reduce Cardiovascular Risk in Older People with Cardiovascular Disease: Bridging Evidence Gaps The geriatric population is rapidly increasing and is greatly impacted by cardiovascular disease. Thus, it becomes essential to ‘geriatricise’ the cardiologist through the dissemination of geriatric cardiology. In the early days of geriatric cardiology, it was questioned whether it was simply cardiology ‘well done’. Today, some 40 years later, i...
PubDate: Mon, 24 Apr 2023 06:44:18 +000
- The 2022 European Society of Cardiology Cardio-oncology Guidelines in
Focus
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus The publication of the 2022 European Society of Cardiology (ESC) cardio-oncology guidelines provides an important milestone in the cardiovascular care of adult cancer patients and adult survivors of childhood and adolescent cancers.1 The recommendations were developed through a concerted international effort, with collaboration from the ESC, the European Society for Therapeutic Radiology and Oncology...
PubDate: Fri, 21 Apr 2023 07:08:46 +000
- Fulminant Myocarditis: When One Size Does Not Fit All – A Critical
Review of the Literature
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature The definition of ‘fulminant’ myocarditis (FM) was first used in 1991 to describe an uncommon, severe form of biopsy-proven myocarditis that had cardiogenic shock (CS) with acute left ventricular failure as the initial presentation.1 The term FM is still used to define the most acute and life-threatening presentation of myocarditis, characterised by sudden onset and a rapid clinical d...
PubDate: Thu, 20 Apr 2023 07:41:09 +000
- Perspectives and Future Directions of Anticoagulant Therapy in Coronary
Artery Disease Patients
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients The use of antiplatelet agents to prevent ischaemic events in atherosclerotic cardiovascular diseases is well established. Coagulation pathways are involved in platelet activation and contribute to thrombus formation irrespective of whether this is within the arterial or venous circulation. The usefulness of oral anticoagulants (OACs), particularly non-vitamin K antagonist OACs (N...
PubDate: Tue, 18 Apr 2023 07:32:12 +000
- Present and Future Perspectives on the Role of Biomarkers in
Atherosclerotic Cardiovascular Disease Risk Stratification
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Present and Future Perspectives on the Role of Biomarkers in Atherosclerotic Cardiovascular Disease Risk Stratification Atherosclerotic cardiovascular diseases (ASCVD) remain the leading cause of death in Europe, with more than 4 million deaths in 2017.1 Ischaemic heart disease and stroke account for 82% of disability-adjusted life years (DALYs) in European Society of Cardiology member countries, even though ASCVD incidence has declined during the past 27 years.1ASCVDs are...
PubDate: Tue, 18 Apr 2023 07:31:58 +000
- ESC Congress 2022 Imaging Highlights
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: ESC Congress 2022 Imaging Highlights Cardiac imaging is an ever-evolving area, with imaging parameters and application in constant re-evaluation. This was reflected in many imaging debates and by the increased number of scientific contributions at ESC Congress 2022.The Danish-NICAD2 study, presented in the Hot Line Sessions, evaluated the role of stress cardiac magnetic resonance (CMR) and PET in patients with coronary lesions of unclear significance on CT.1 The performanc...
PubDate: Thu, 06 Apr 2023 10:52:29 +000
- Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary
Hypertension: Clinical Outcomes
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Clinical Outcomes Chronic thromboembolic pulmonary hypertension (CTEPH) is characterised by fibrothrombotic material mechanically obliterating major pulmonary arteries, resulting in increased pulmonary vascular resistance (PVR), progressive pulmonary hypertension (PH) combined with a microscopic pulmonary vasculopathy, right ventricular (RV) failure and premature death.1,2 The survival of patien...
PubDate: Wed, 05 Apr 2023 10:34:01 +000
- Sex Differences in Outcome and Prescribing Practice in ST-elevation MI
Patients with Multivessel Disease and Incomplete Revascularisation
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Sex Differences in Outcome and Prescribing Practice in ST-elevation MI Patients with Multivessel Disease and Incomplete Revascularisation Women have a poorer prognosis following ST-elevation MI (STEMI) than men.1–7 Although sex-based differences in post-STEMI outcome are well documented, the reasons for these poorer outcomes in women are less well defined, which limits our ability to close this sex-based outcome gap. The role played by differences in the anatomical complexit...
PubDate: Tue, 04 Apr 2023 10:51:28 +000
- Noise, Air, and Heavy Metal Pollution as Risk Factors for Endothelial
Dysfunction
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Noise, Air, and Heavy Metal Pollution as Risk Factors for Endothelial Dysfunction Environmental stressors, such as noise, air or heavy metal pollution, represent important risk factors for the development and progression of cardiovascular disease (CVD).1–5 The WHO estimates that at least 1.6 million healthy life years are lost every year in western European countries alone due to the exposure to environmental noise. Additionally, within the last years, the GBD study establis...
PubDate: Tue, 04 Apr 2023 09:58:28 +000
- Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in
Women’s Hearts'
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts' Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women.1 One in 8.3 deaths was attributed to coronary heart disease (CHD) in women, whereas one in 31.5 deaths was attributed to breast cancer (BC) in 2017.2In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT)....
PubDate: Wed, 29 Mar 2023 12:23:25 +000
- Coronary Microvascular Spasm: Clinical Presentation and Diagnosis
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Coronary Microvascular Spasm: Clinical Presentation and Diagnosis Professor Maseri was a pioneer who blazed a trail in the field of coronary vasomotion abnormalities from its dawning age and was one of the most prominent physician-scientists represented in the history of the field.1,2 More than 40 years ago, he demonstrated that myocardial ischaemia can be caused by coronary vasomotion abnormalities, such as coronary vasospasm and distal coronary constriction, even in the ab...
PubDate: Tue, 21 Mar 2023 10:31:16 +000
- Sex-based Differences in Percutaneous Coronary Intervention Outcomes in
Patients With Ischemic Heart Disease
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients With Ischemic Heart Disease Cardiovascular disease (CVD) is the leading cause of death for women globally. In Europe, CVD accounts for 45% of deaths in women and 39% of deaths in men.1 In the US, between 1994 and 2020 mortality due to CVD decreased in both sexes, but less for young women (≤55 years) compared to young men.2 Advances in therapeutic options have contributed to these improvements. E...
PubDate: Thu, 02 Mar 2023 08:25:06 +000
- Time to Integrate Sex in Management of Aortic Valve Stenosis
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Time to Integrate Sex in Management of Aortic Valve Stenosis An increasing body of evidence demonstrates how sex influences the development of degenerative aortic valve stenosis (AS) at the aortic root, the valvular and the left ventricular (LV) levels. While the sex-specific impact of ageing and comorbidities promote differences in remodelling of the aortic root and the LV in AS,1,2 sex differences in tissue biology have been demonstrated in the aortic valve.3 These documen...
PubDate: Thu, 16 Feb 2023 10:58:47 +000
- Cardio-oncology in 2022
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Cardio-oncology in 2022 Cardio-oncology is a multidisciplinary, collaborative specialty that focuses on the cardiac care of cancer patients before, during and after their cancer treatment. As the incidence of and survival from cancer has increased, the sub-specialty of cardio-oncology has developed, with ever-increasing patient demand and increasing recognition in the literature. Cardiovascular disease (CVD) and cancer share multiple risk factors, with the incidence of CVD m...
PubDate: Thu, 16 Feb 2023 10:52:04 +000
- Dyspnea in Oncological Patients: a Brain Teaser
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Dyspnea in Oncological Patients: a Brain Teaser Dyspnea is one of the most distressing and debilitating symptoms experienced by oncological patients, usually in association with fatigue, anxiety and depression. It is also disturbing and upsetting to family members, leading to functional limitations in patients and a compromised quality of life (QoL) for both patients and caregivers.Definition of dyspneaThe term ‘dyspnea’ comes from two Greek words: dus (difficult) and pn...
PubDate: Fri, 03 Feb 2023 07:09:59 +000
- Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure
with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis Heart failure (HF) is a clinical syndrome that arises from a variety of heart diseases.1 The American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) define HF as a complex clinical syndrome resulting from structural or functional disturbances of ventricular filling or blood ejection.2 There are some fun...
PubDate: Sat, 21 Jan 2023 02:04:45 +000
- Comment on the ESC Guidelines 2022 for the Management of Patients with
Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Authors: c242508f1d9059bc0f2aa9bdd5421ba2
Abstract: Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Sudden cardiac death (SCD) and ventricular arrhythmias (VA) are responsible for a significant proportion of deaths, so have a tremendous impact not only on patients and medical practice but also on families, the health authorities and the general population, and are often featured on social media.Stratification of risk in patients, their...
PubDate: Fri, 20 Jan 2023 14:34:55 +000
